
Business of Cannabis Europe

MGC Pharmaceuticals Ltd Announces Completion Of CimetrA Mechanism Of Action Study
PRESS RELEASE Key Highlights: MGC Pharma has completed an in-vitro pre-clinical study on CimetrA™’s mechanism of action (MoA) The study,